Article
CRISPR/SaCas9-based gene editing rescues photoreceptor degeneration throughout a rhodopsin-associated autosomal dominant retinitis pigmentosa mouse model.
Experimental biology and medicine (Maywood, N.J.) - 1 Oct 2023
Du Wei, Li Jiarui, Tang Xin, Yu Wenzhen, Zhao Mingwei
Abstract excerpt
Rhodopsin (Rho) gene mutation was considered the highest prevalent mutation in autosomal dominant retinitis pigmentosa (ADRP); however, effective therapeutics for ADRP have not been developed. The process of gene editing via the clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 system offers the potentiality to provide cures for dominantly inherited disorders. Herein, we generated a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
